Overnight and In-house 3D-printed Patient-specific Casts for Non-operative Treatment of Distal Radius Fractures (3D-cast)

April 23, 2022 updated by: Alissa Gubeli

Overnight and In-house 3D-printed Patient-specific Casts for Non-operative Treatment of Distal Radius Fractures - a Prospective Randomized Trial

The aim of this prospective randomized trial is the acquisition and evaluation of data to assess the relevance, feasibility and safety of forearm casts based on 3D-printing technology in the nonoperative treatment of distal radius fractures.

Study Overview

Status

Completed

Detailed Description

The study design is planned according to similar studies investigating the treatment of distal radius fractures.

Upon the patient's arrival at the emergency unit, the distal radius fracture is examined following the same scheme as before. The wrist is x-rayed in two planes. If there is a distal radius fracture and none of the exclusion criteria apply, the patient is included in the study after giving their consent in writing. The patients are then assigned to the "conventional cast" group (Group A) or the "3D print cast" group (Group B) in randomized trial, either immediately during the emergency consultation or within a week during hand surgery consultation hours. For initial immobilization, a thermoplastic cast splint is used as before. Depending on the randomization, the cast is changed to a Scotchcast cast (Group A) or a 3D printed cast (Group B). Further treatment of both groups occurs based on the same algorithm as before (see below).

The cast for Group B are produced using 3D print technology based on software by a Belgian company, our collaborators: The patient's forearm is scanned with a tablet (duration: approx. 5 min), whereupon the cast is printed overnight according to the scan (duration: approx. 4h) and adjusted to the patient during the next appointment.

The patients are examined after 1, 6, 12, 26 and 52 weeks in the outpatient clinic. Follow up x rays, patient satisfaction and clinical efficacy questionnaires and clinical examinations are conducted.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baselland
      • Bruderholz, Baselland, Switzerland, 4101
        • Kantonsspital Baselland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Undisplaced or minimally displace distal radius fractures

Exclusion Criteria:

  1. Age < 18yrs.
  2. Dorsal dislocation (dp angle) >20°
  3. Palmar dislocation
  4. Ad latus dislocation
  5. Radio-/ulnar angulation in the coronary plane
  6. Symptoms of neurologic affection (Median nerve)
  7. Bilateral fractures
  8. Previous ipsilateral distal radius fracture
  9. The patient is unable to give informed consent due to physical or mental impairment
  10. The patient is unavailable for follow-up examinations (foreign country, Polytrauma, etc)
  11. The patient is under legal custodianship
  12. C2- or Drug-abuse or expected incompliance
  13. Hypersensitivity/Allergy to one or more components of the used casts
  14. Pregnancy/Intention to become pregnant during the course of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3D-printed cast
Treatment of distal radius fracture with 3D-printed forearm cast.
The 3D-printed casts are produced using 3D print technology based on software by Belgian software company: The patient's forearm is scanned with a tablet (duration: approx. 5 min), whereupon the cast is printed overnight according to the scan (duration: approx. 4h) and adjusted to the patient during the next appointment.
Active Comparator: Conventional cast
Treatment of distal radius fracture with conventional plaster cast.
A conventional plaster cast is applied for treatment of the distal radius fracture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of modified patient satisfaction questionnaire
Time Frame: 1 year
quantified with questionnaire (0-12, 0=worst result)
1 year
Score of clinical effectiveness questionnaire
Time Frame: 1 year
quantified with questionnaire (0-12, 0=worst result)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fracture healing
Time Frame: 1 year
assessed with X-ray pictures taken during the follow-up, consolidation signs
1 year
Score on Visual Analogue Pain Scale
Time Frame: 1 year
assessed using the Visual Analogue Pain Scale (0-10, 0=best result, no pain)
1 year
Amount of range of motion in degrees
Time Frame: 1 year
assessed/measured by the physician with a goniometer (°, 0-360°)
1 year
Amount of grip strength in (N/kg)
Time Frame: 1 year
assessed with a dynamometer (N/kg, the lower the weaker)
1 year
Score of Disabilities of Arm, Shoulder and Hand
Time Frame: 1 year
assessed with Disabilities of Arm, Shoulder and Hand score (0-100, 0=best result, no impairment)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Philipp Honigmann, PD Dr. med., Kantonsspital Baselland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

April 17, 2022

First Submitted That Met QC Criteria

April 23, 2022

First Posted (Actual)

April 26, 2022

Study Record Updates

Last Update Posted (Actual)

April 26, 2022

Last Update Submitted That Met QC Criteria

April 23, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radius Fracture Distal

Clinical Trials on 3D-printed cast

Subscribe